Austin Mark John (CIK 0001713059)

Latest company ownership

CATX - Perspective Therapeutics, Inc.

Role: VP Finance/Prin Fin&Acct Offic

Shares held

34,500

Last filed at

Jul 19, 2024

Confidence Score

50.0

2025Q4

Confidence Score History

2017Q4 2025Q4

Recent buy/sell transactions

Exec date	Filing date	Company	Role	Signal	Confidence	Shares	% of shares	Under plan?	Amount (USD)
Jun 8, 2022	Jun 9, 2022	Perspective Therapeutics, Inc.	VP Finance/Prin Fin&Acct Offic	Buy	90.0	+18,800	53.36%	✗	$5.4K
Oct 22, 2020	Oct 28, 2020	Perspective Therapeutics, Inc.	Controller/Prin Fin&Acct Offic	Buy	90.0	+19,230	120.19%	✗	$10K
Nov 16, 2018	Nov 20, 2018	Perspective Therapeutics, Inc.	Controller/Prin Fin&Acct Offic	Buy	90.0	+4,283	36.55%	✗	$1.7K
Nov 13, 2018	Nov 15, 2018	Perspective Therapeutics, Inc.	Controller/Prin Fin&Acct Offic	Buy	90.0	+2,452	26.47%	✗	$1K
Nov 21, 2017	Nov 24, 2017	Perspective Therapeutics, Inc.	Controller/Prin Fin&Acct Offic	Buy	90.0	+9,265	100.00%	✗	$4.5K